|
|
 |
The following are a list of recent grants made available in North America or Internationally to support instrumentation and/or application development and research in areas where VisEn’s FMT 2500™ quantitative tomography imaging system and our range of fluorescent in vivo imaging agents as assist in quantifying biomarkers for disease and therapeutic efficacy in vivo:
 |
 |
|
National Institute of Biomedical Imaging and Bioengineering Program Project (P01) Applications
http://grants.nih.gov/grants/guide/pa-files/PAR-10-233.html
Release Date: July 20, 2010
Program Announcement (PA) Number: PAR-10-233 Purpose. This FOA, issued by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Insitutes of Health, encourages investigator-initiated Program Project Grant (P01) applications from institutions/organizations in the broad areas of biomedical imaging and bioengineering enabled by relevant areas of the physical sciences, engineering, computer sciences, information science, and the medical and life sciences. P01 grants are to support broad-based multidisciplinary research programs, which have a well-defined major objective or central theme, but which are addressing a range of imaging or bioengineering questions in contrast to the traditional research project (R01). - Budget and Project Period. Budgets for direct costs per year will depend upon specific project requirements, and a project duration of up to five years may be requested. The expected direct cost for program project awards is $1.2-1.4 million per year for most studies within the scope of this FOA.
|
|
|
|
Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage I (CADET I) (P50)
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-11-015.html
Release Date: February 26, 2010
Letters of Intent Receipt Date: April 12, 2010
Expiration Date: May 13, 2010 Purpose. The purpose of this FOA issued by the NHLBI, National Institutes of Health, is to invite applications for clinical research centers for Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage I (CADET I). The overall goal of the CADET program (Stages I and II) is to accelerate the development of novel agents for the diagnosis and treatment of lung diseases and sleep disordered breathing through the use of rational strategies based on fundamental pathobiologic processes. CADET I provides the opportunity to explore potential target(s) for validation to determine which are amenable for development of mechanism-based modalities for direct clinical application in the prevention, diagnosis, and treatment of pulmonary diseases and sleep disordered breathing. |
|
|
|
Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)
|
|
|
|
Shared Instrumentation Grant Program (S10)
|
|
|
|
Developing Technologies for Improved In Vivo Epigenetic Imaging or Analysis (R01)
|
|
|
|
Recovery Act Limited Competition: NIH Challenge Grants in Health and Science Research (RC1)
|
|
|
|
Recovery Act Limited Competition: Core Facility Renovation, Repair, and Improvement (G20)
|
|
|
|
Recovery Act Limited Competition: Extramural Research Facilities Improvement Program (C06)
(RFA-RR-09-008) National Center for Research Resources American Reinvestment and Recovery Act of 2009 Application Receipt Date(s): May 6, 2009 (projects between $2M and $5M); June 17, 2009 (projects between $10M and $15M), July 17, 2009 (projects between $5M and $10M) http://grants.nih.gov/grants/guide/rfa-files/RFA-RR-09-008.html |
|
|
|
Addition of Recovery Funds to the Shared Instrumentation Grant Program
|
|
|
|
Shared Instrumentation Grant (S 10)
|
|
|
|
Innovation in Molecular Imaging Probes (R01)
|
|
